Covishield is safe and there is "no signal of concern" regarding it as of now, the Centre asserted on Wednesday amid reports of possible side-effects of the Oxford-AstraZeneca''s COVID-19 vaccine and its suspension in some European countries.

The AEFI committee which closely keeps track and records adverse events following immunisations has "concluded that thrombosis events due to Covishield in India is not a problem".